| Age | 66.2 ± 3.4 |
| Sex (male/female) | 18/14 |
| Comorbidity | |
| Diabeticmellitus | 20 (62.5%) |
| Hypertension | 22 (68.8%) |
| Dyslipidemia | 18 (56.3%) |
| COPD | 5 (15.6%) |
| Hx of stroke | 2 (6.3%) |
| Cr level > 1.5 | 4 (12.5%) |
| Atrial fibrillation | 8 (25%) |
| STS score | 3.2 ± 0.21 |
| NYHA Class | |
| II | 8 (25%) |
| III | 17 (53.1%) |
| IV | 7 (21.4%) |
| Preoperative IABP | 1 (3.1%) |
| Preoperative medication | |
| Loop diuretic | 25 (78.1%) |
| Anti-aldosterone | 23 (71.9%) |
| Beta block | 24 (75%) |
| ACEi or ARB | 26 (81.3%) |
| Etiology of MR | |
| Ischemic | 27 (84.4%) |
| Nonischemic | 5 (15.6%) |
| Echocardiogram | |
| MR grade | |
| moderate (ERO 0.2 - 0.4 cm2) | 3 (9.4%) |
| severe (ERO > 0.4 cm2) | 29 (91.6%) |
| EF | 38.2 ± 10.8 |
| LVEDD (mm) | 62.8 ± 5.3 |
| LVESD (mm) | 50.2 ± 6.3 |
| LVEDVi (ml/m2) | 117.2 ± 18.9 |
| LVESVi (ml/mm2) | 68.6 ± 24.3 |
| Tenting depth (cm) | 1.18 ± 0.06 |
| Tenting area (cm2) | 2.61 ± 0.58 |
| TRPG (mmHg) | 32.9 ± 9.5 |
| TR grade | |
| severe | 7 (21.8%) |
| moderate | 1 (3.1%) |